Buckell N A, Gould S R, Day D W, Lennard-Jones J E, Edwards A M
Gut. 1978 Dec;19(12):1140-3. doi: 10.1136/gut.19.12.1140.
Oral disodium cromoglycate (200 mg qds) has been tested in 26 patients with ulcerative colitis that was resistant to medical treatment. In a double-blind crossover trial disodium cromoglycate and placebo were added to conventional treatment in random order, each for four weeks. There was no significant difference in therapeutic effect between disodium cromoglycate and placebo.
口服色甘酸钠二钠(200毫克,每日四次)已在26例对药物治疗有抵抗性的溃疡性结肠炎患者中进行了测试。在一项双盲交叉试验中,色甘酸钠二钠和安慰剂以随机顺序添加到常规治疗中,各为期四周。色甘酸钠二钠和安慰剂之间的治疗效果没有显著差异。